Avid Bioservices Stock Performance
| CDMO Stock | USD 12.35 0.02 0.16% |
On a scale of 0 to 100, Avid Bioservices holds a performance score of 9. The firm shows a Beta (market volatility) of 1.26, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Avid Bioservices will likely underperform. Please check Avid Bioservices' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Avid Bioservices' price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Avid Bioservices are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, Avid Bioservices displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 38.9 M |
Avid |
Avid Bioservices Relative Risk vs. Return Landscape
If you would invest 973.00 in Avid Bioservices on August 31, 2024 and sell it today you would earn a total of 262.00 from holding Avid Bioservices or generate 26.93% return on investment over 90 days. Avid Bioservices is currently generating 0.4423% in daily expected returns and assumes 3.662% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Avid, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Avid Bioservices Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avid Bioservices' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Avid Bioservices, and traders can use it to determine the average amount a Avid Bioservices' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1208
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CDMO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.66 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.44 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Avid Bioservices is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avid Bioservices by adding it to a well-diversified portfolio.
Avid Bioservices Fundamentals Growth
Avid Stock prices reflect investors' perceptions of the future prospects and financial health of Avid Bioservices, and Avid Bioservices fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Avid Stock performance.
| Return On Equity | -1.16 | ||||
| Return On Asset | -0.0305 | ||||
| Profit Margin | (1.01) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 962.43 M | ||||
| Shares Outstanding | 63.96 M | ||||
| Price To Earning | 10.76 X | ||||
| Price To Book | 13.45 X | ||||
| Price To Sales | 5.55 X | ||||
| Revenue | 139.91 M | ||||
| EBITDA | (11.48 M) | ||||
| Cash And Equivalents | 115.14 M | ||||
| Cash Per Share | 1.85 X | ||||
| Total Debt | 207.83 M | ||||
| Debt To Equity | 1.02 % | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | 10.95 M | ||||
| Earnings Per Share | (2.29) X | ||||
| Total Asset | 336.56 M | ||||
| Retained Earnings | (571.87 M) | ||||
| Current Asset | 25.65 M | ||||
| Current Liabilities | 10.9 M | ||||
About Avid Bioservices Performance
By examining Avid Bioservices' fundamental ratios, stakeholders can obtain critical insights into Avid Bioservices' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Avid Bioservices is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people.Things to note about Avid Bioservices performance evaluation
Checking the ongoing alerts about Avid Bioservices for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Avid Bioservices help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Avid Bioservices had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 139.91 M. Net Loss for the year was (140.75 M) with profit before overhead, payroll, taxes, and interest of 31.48 M. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Avid Bioservices' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Avid Bioservices' stock is overvalued or undervalued compared to its peers.
- Examining Avid Bioservices' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Avid Bioservices' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Avid Bioservices' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Avid Bioservices' stock. These opinions can provide insight into Avid Bioservices' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.